Bumhee Yang, Hayoung Choi, Sun-Kyung Lee, Sung Jun Chung, Yoomi Yeo, Yoon Mi Shin, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Yun Su Sim, Ho Joo Yoon, Jang Won Sohn, Hyun Lee, Sang-Heon Kim
Cancer Res Treat. 2021;53(3):678-684. Published online December 28, 2020
Purpose This study aimed to analyze whether patients with lung cancer have a higher susceptibility of coronavirus disease 2019 (COVID-19), severe presentation, and higher mortality than those without lung cancer.
Materials and Methods A nationwide cohort of confirmed COVID-19 (n=8,070) between January 1, 2020, and May 30, 2020, and a 1:15 age-, sex-, and residence-matched cohort (n=121,050) were constructed. A nested case-control study was performed to compare the proportion of patients with lung cancer between the COVID-19 cohort and the matched cohort.
Results The proportion of patients with lung cancer was significantly higher in the COVID-19 cohort (0.5% [37/8,070]) than in the matched cohort (0.3% [325/121,050]) (p=0.002). The adjusted odds ratio [OR] of having lung cancer was significantly higher in the COVID-19 cohort than in the matched cohort (adjusted OR, 1.51; 95% confidence interval [CI], 1.05 to 2.10). Among patients in the COVID-19 cohort, compared to patients without lung cancer, those with lung cancer were more likely to have severe COVID-19 (54.1% vs. 13.2%, p < 0.001), including mortality (18.9% vs. 2.8%, p < 0.001). The adjusted OR for the occurrence of severe COVID-19 in patients with lung cancer relative to those without lung cancer was 2.24 (95% CI, 1.08 to 4.74).
Conclusion The risk of COVID-19 occurrence and severe presentation, including mortality, may be higher in patients with lung cancer than in those without lung cancer.
Citations
Citations to this article as recorded by
Impact of physical activity on all-cause mortality in individuals with non-cystic fibrosis bronchiectasis Sang Hyuk Kim, Hayoung Choi, Kyungdo Han, Jin-Hyung Jung, Bumhee Yang, Hyun Lee Frontiers in Medicine.2025;[Epub] CrossRef
Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study Bo-Guen Kim, Hyun Lee, Yeonghee Eun, Kyungdo Han, Jin-Hyung Jung, Hayoung Choi, Hyungjin Kim, Dong Wook Shin Scientific Reports.2025;[Epub] CrossRef
COVID-19 and risk of long-term mortality in COPD: a nationwide population-based cohort study Hyun Lee, Sang Hyuk Kim, Cho Yun Jeong, Jee-Eun Chung, Youlim Kim, Kyung Hoon Min, Kwang Ha Yoo, Jong Seung Kim, Ji-Yong Moon BMJ Open Respiratory Research.2025; 12(1): e002694. CrossRef
Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study Bo-Guen Kim, Jiyeong Kim, Yeonghee Eun, Dong Won Park, Sang-Heon Kim, Hyun Lee RMD Open.2025; 11(1): e005267. CrossRef
Risk of acute exacerbation of chronic obstructive pulmonary disease after COVID-19 recovery: a nationwide population-based cohort study Sang Hyuk Kim, Hyun Lee, Min Ji Kim, Youlim Kim, Kyung Hoon Min, Kwang Ha Yoo, Jong Seung Kim, Ji-Yong Moon Respiratory Research.2025;[Epub] CrossRef
Increased risk of suicide among individuals with chronic obstructive pulmonary disease: A nationwide cohort study in Korea Sang Hyuk Kim, Ji-Yong Moon, Taehee Kim, Jin-Hyung Jung, Kyungdo Han, Kyung Hoon Min, Hyun Lee Journal of Affective Disorders.2025; 381: 507. CrossRef
ВЛИЯНИЕ СОПУТСТВУЮЩИХ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ НА ТЕЧЕНИЕ И ЛЕТАЛЬНОСТЬ COVID-19
Андрей Михайлович Сарана, Сергей Григорьевич Щербак, Дмитрий Александрович Вологжанин, Александр Сергеевич Голота, Сергей Владимирович Кадин, Татьяна Аскаровна Камилова University therapeutic journal.2025; 7(1): 14. CrossRef
Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study Jong Geol Jang, Hyun Lee, Min Gu Kang, Youlim Kim, Kwang Ha Yoo, Kyung Hoon Min, June Hong Ahn, Kyung Soo Hong, Jong Seung Kim, Ji-Yong Moon BMJ Open Respiratory Research.2025; 12(1): e002373. CrossRef
Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study Bo-Guen Kim, Hyun Lee, Sang Woo Yeom, Cho Yun Jeong, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Jong Seung Kim, Sang-Heon Kim The Journal of Allergy and Clinical Immunology: In Practice.2024; 12(1): 120. CrossRef
Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study Bo-Guen Kim, Hyun Lee, Cho Yun Jeong, Sang Woo Yeom, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Jong Seung Kim, Sang-Heon Kim Frontiers in Public Health.2024;[Epub] CrossRef
Microwave ablation for high-risk pulmonary nodules in patients infected with the Omicron variant of Sars-Cov-2 within 3 months: a retrospective analysis of safety and efficacy Yuxian Chen, Yang Li, Hong Meng, Chunhai Li, Fanlei Kong Frontiers in Oncology.2024;[Epub] CrossRef
A year of experience with COVID‐19 in patients with cancer: A nationwide study Mina Khosravifar, Sogol Koolaji, Negar Rezaei, Ali Ghanbari, Seyedeh Melika Hashemi, Erfan Ghasemi, Ali Bitaraf, Ozra Tabatabaei‐Malazy, Nazila Rezaei, Sahar Mohammadi Fateh, Arezou Dilmaghani‐Marand, Rosa Haghshenas, Ameneh Kazemi, Erfan Pakatchian, Farz Cancer Reports.2023;[Epub] CrossRef
Risk factors for mortality among lung cancer patients with covid-19 infection: A systematic review and meta-analysis Mingyue Wu, Siru Liu, Changyu Wang, Yuxuan Wu, Jialin Liu, Yoon-Seok Chung PLOS ONE.2023; 18(9): e0291178. CrossRef
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials Matthew P. Smeltzer, Giorgio V. Scagliotti, Heather A. Wakelee, Tetsuya Mitsudomi, Upal Basu Roy, Russell C. Clark, Renee Arndt, Clayton D. Pruett, Karen L. Kelly, Peter Ujhazy, Melissa L. Johnson, Yesim Eralp, Carlos H. Barrios, Fabrice Barlesi, Fred R. Journal of Thoracic Oncology.2022; 17(5): 651. CrossRef
Conceptual Framework for Cancer Care During a Pandemic Incorporating Evidence From the COVID-19 Pandemic Vivienne Milch, Anne E. Nelson, Melissa Austen, Debra Hector, Scott Turnbull, Rahul Sathiaraj, Carolyn Der Vartanian, Rhona Wang, Cleola Anderiesz, Dorothy Keefe JCO Global Oncology.2022;[Epub] CrossRef
COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-Analysis Simone Oldani, Fausto Petrelli, Giuseppina Dognini, Karen Borgonovo, Maria Chiara Parati, Mara Ghilardi, Lorenzo Dottorini, Mary Cabiddu, Andrea Luciani Cancers.2022; 14(22): 5706. CrossRef
Interstitial lung disease increases susceptibility to and severity of COVID-19 Hyun Lee, Hayoung Choi, Bumhee Yang, Sun-Kyung Lee, Tai Sun Park, Dong Won Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Sang-Heon Kim European Respiratory Journal.2021; 58(6): 2004125. CrossRef
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis Marco Tagliamento, Elisa Agostinetto, Marco Bruzzone, Marcello Ceppi, Kamal S. Saini, Evandro de Azambuja, Kevin Punie, C. Benedikt Westphalen, Gilberto Morgan, Paolo Pronzato, Lucia Del Mastro, Francesca Poggio, Matteo Lambertini Critical Reviews in Oncology/Hematology.2021; 163: 103365. CrossRef
Characteristics and outcomes of the Korean patients with coronavirus disease 2019; analyses of the national database Sang-Heon Kim Allergy, Asthma & Respiratory Disease.2021; 9(3): 113. CrossRef